Summary
Canadeans Biostime International Holdings Limited : Food Company Profile, SWOT and Financial Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.
Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about Biostime International Holdings Limited
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Synopsis
Biostime International Holdings Limited (Biostime) is a provider of pediatric nutrition and baby care products based in China. It offers probiotic supplements, infant formula, dried baby food, nutrition supplements and baby care products under five brands: Adimil, Biostime, Parenting Power, BMcare and Mama100. It offers various value-added services including, professional magazine, mama100 mobile app, nursing consulting hotline, mama100.com website, training program and membership point accumulation program to its members and member retail outlets through its MAMA100 membership platform. The company owns high penetration and wide distribution network through its sales offices located across China. Biostime is headquartered in Guangzhou, China.
This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.
The SWOT analysis identifies the companys strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.
The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.
Reasons To Buy
Quickly enhance your understanding of Biostime International Holdings Limited
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
Increase business/sales activities by understanding your competitors businesses better.
Recognize potential partnerships and suppliers.
Key Highlights
Biostime International Holdings Limited (Biostime) is a provider of pediatric nutrition and baby care products based in China. It offers probiotic supplements, infant formula, dried baby food, nutrition supplements and baby care products under five brands: Adimil, Biostime, Parenting Power, BMcare and Mama100. It offers various value-added services including, professional magazine, mama100 mobile app, nursing consulting hotline, mama100.com website, training program and membership point accumulation program to its members and member retail outlets through its MAMA100 membership platform. The company owns high penetration and wide distribution network through its sales offices located across China. Biostime is headquartered in Guangzhou, China.
Table Of Contents
1 Biostime International Holdings Limited
2 Biostime International Holdings Limited - Key Employees
3 Biostime International Holdings Limited - Key Employees Biographies
4 Biostime International Holdings Limited - Major Products and Services
5 Biostime International Holdings Limited - History
6 Biostime International Holdings Limited - Company Statement
7 Biostime International Holdings Limited - Locations and Subsidiaries
7.1 Biostime International Holdings Limited - Head Office
7.2 Biostime International Holdings Limited - Other Locations and Subsidiaries
8 Biostime International Holdings Limited - Business Analysis
8.1 Biostime International Holdings Limited - Company Overview
8.2 Biostime International Holdings Limited - Business Description
9 Biostime International Holdings Limited - SWOT Analysis
9.1 Biostime International Holdings Limited - SWOT Analysis - Overview
9.2 Biostime International Holdings Limited - Strengths
9.2.1 Strength - Strong Financial Performance
9.2.2 Strength - Strategic Partnership
9.2.3 Strength - Strong Store Network
9.3 Biostime International Holdings Limited - Weaknesses
9.3.1 Weakness - Declining Operational Performance
9.3.2 Weakness - Limited Liquidity Position
9.4 Biostime International Holdings Limited - Opportunities
9.4.1 Opportunity - Strategic Growth Initiatives
9.4.2 Opportunity - Improving Economies
9.4.3 Opportunity - Positive Outlook for Infant Formula Products
9.5 Biostime International Holdings Limited - Threats
9.5.1 Threat - Stringent Regulations
9.5.2 Threat - Food Safety
9.5.3 Threat - Expansion by Competitors
10 Biostime International Holdings Limited - Company Financial Analysis
10.1 Biostime International Holdings Limited - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
11 Biostime International Holdings Limited - Interim ratios
11.1.1 Biostime International Holdings Limited - Financial ratios: Capital Market Ratios
11.2 Biostime International Holdings Limited - Financial Performance and Ratio Charts
11.2.1 Biostime International Holdings Limited - Revenue and Operating margin
11.2.2 Biostime International Holdings Limited - Asset and Liabilities
11.2.3 Biostime International Holdings Limited - Net Debt vs. Gearing Ratio
11.2.4 Biostime International Holdings Limited - Operational Efficiency
11.2.5 Biostime International Holdings Limited - Solvency
11.2.6 Biostime International Holdings Limited - Valuation
11.3 Biostime International Holdings Limited - Competitive Benchmarking
11.3.1 Biostime International Holdings Limited - Market Capitalization
11.3.2 Biostime International Holdings Limited - Efficiency
11.3.3 Biostime International Holdings Limited - Valuation
11.3.4 Biostime International Holdings Limited - Turnover: Inventory and Asset
11.3.5 Biostime International Holdings Limited - Liquidity
12 Biostime International Holdings Limited - Recent Developments
13 Appendix
13.1 Methodology
13.2 Biostime International Holdings Limited - Ratio Definitions
13.3 Disclaimer
List Of Tables
Table 1: Biostime International Holdings Limited - Key Employees
Table 2: Biostime International Holdings Limited - Key Employees Biographies
Table 3: Biostime International Holdings Limited - Major Products and Services
Table 4: Biostime International Holdings Limited - History
Table 5: Biostime International Holdings Limited - Subsidiaries
Table 6: Biostime International Holdings Limited - Annual ratios
Table 7: Biostime International Holdings Limited - Interim ratios
Table 8: Biostime International Holdings Limited - Capital Market Ratios
List Of Figures
Figure 1: Biostime International Holdings Limited - Revenue and Operating Profit
Figure 2: Biostime International Holdings Limited - Asset and Liabilities
Figure 3: Biostime International Holdings Limited - Net Debt vs. Gearing Ratio
Figure 4: Biostime International Holdings Limited - Operational Efficiency
Figure 5: Biostime International Holdings Limited - Solvency
Figure 6: Biostime International Holdings Limited - Valuation
Figure 7: Biostime International Holdings Limited - Market Capitalization
Figure 8: Biostime International Holdings Limited - Efficiency
Figure 9: Biostime International Holdings Limited - Valuation
Figure 10: Biostime International Holdings Limited - Turnover: Inventory and Asset
Figure 11: Biostime International Holdings Limited - Liquidity
